Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$343.0 - $410.68 $7.52 Million - $9.01 Million
21,934 Added 316.01%
28,875 $11.7 Million
Q3 2023

Nov 02, 2023

SELL
$338.18 - $362.46 $37,876 - $40,595
-112 Reduced 1.59%
6,941 $2.41 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $126,711 - $141,819
-403 Reduced 5.41%
7,053 $2.48 Million
Q1 2023

May 03, 2023

SELL
$283.23 - $323.1 $337,326 - $384,812
-1,191 Reduced 13.77%
7,456 $2.35 Million
Q4 2022

Feb 07, 2023

BUY
$285.76 - $321.48 $391,776 - $440,749
1,371 Added 18.84%
8,647 $2.5 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $641,309 - $715,551
2,342 Added 47.47%
7,276 $2.11 Million
Q2 2022

Jul 29, 2022

BUY
$234.96 - $292.55 $955,112 - $1.19 Million
4,065 Added 467.78%
4,934 $1.39 Million
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $192,413 - $226,782
869 New
869 $227,000
Q4 2021

Feb 07, 2022

SELL
$177.01 - $223.45 $9.53 Million - $12 Million
-53,823 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$181.39 - $202.99 $9.76 Million - $10.9 Million
53,813 Added 538130.0%
53,823 $9.76 Million
Q2 2021

Jul 29, 2021

BUY
$187.49 - $221.1 $1,874 - $2,211
10 New
10 $2,000
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $80,116 - $93,386
-387 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $98,936 - $117,299
387 New
387 $105,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.